Financials

Annual Reports

Financial Reports

Fiscal Year First Quarter Second Quarter Third Quarter Information Circular Financials & MD&A Annual Report

Tax Information

PASSIVE FOREIGN INVESTMENT COMPANY
PFIC Annual Information Statement (2014 Tax Year) PFIC Annual Information Statement (2013 Tax Year) PFIC Annual Information Statement (2012 Tax Year) PFIC Annual Information Statement (2011 Tax Year) PFIC Annual Information Statement (2010 Tax Year)

DISCLAIMER: THIS INFORMATION IS PROVIDED IN ORDER TO ASSIST SHAREHOLDERS IN MAKING CALCULATIONS AND DOES NOT CONSTITUTE TAX ADVICE. SHAREHOLDERS ARE ADVISED TO CONSULT THEIR OWN TAX ADVISORS CONCERNING THE OVERALL TAX CONSEQUENCES OF THE OWNERSHIP OF COMMON SHARES ARISING IN THEIR OWN PARTICULAR SITUATIONS UNDER UNITED STATES FEDERAL, STATE, LOCAL OR FOREIGN LAW.

Filings

SEDAR View our filings as a publicly listed company in Canada (TSX).

EDGAR Our SEC filings as a publicly listed company in the United States (NASDAQ).

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Latest News

April 20, 2015 Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 2015 AACR Annual Meeting
April 17, 2015 Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Malignant Gliomas
April 15, 2015 Oncolytics Biotech® Inc. Presents at UK Immuno-oncology Meeting
Sign up to receive e-mail updates *